FormulaFolio Investments’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-769,762
Closed -$18.2M 670
2020
Q3
$18.2M Buy
+769,762
New +$18.4M 0.7% 37

Other funds holding BTAL

FormulaFolio Investments's BTAL Position: Q4 2020 in Review

FormulaFolio Investments sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2020, closing a stake of 769,762 shares — an estimated $18.2M sold.

FormulaFolio Investments first reported a position in BTAL in Q3 2020 and held it in 1 quarter. The position peaked at $18.2M in Q3 2020. 36 funds tracked by Wall St. Rank hold BTAL as of Q4 2020.

  • FormulaFolio Investments reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2020 after selling out during the quarter.
  • FormulaFolio Investments sold 769,762 AGF US Market Neutral Anti-Beta Fund shares in Q4 2020, an estimated $18.2M.
  • FormulaFolio Investments first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2020 and held it in 1 quarter.
  • FormulaFolio Investments's AGF US Market Neutral Anti-Beta Fund position peaked at $18.2M in Q3 2020.
  • 36 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2020.

Based on FormulaFolio Investments's 13F filing for Q4 2020, filed 2 Mar 2021.